METHOD OF FORECASTING OF INEFFICIENCY LASER DESCEMETOGONIOPUNCTURE CAUSED BY OFTALMOHYPERTENSION RELAPSE LONG DATE FOLLOWING NON-PENETRATING ANTIGLAUCOMATOUS OPERATIONS Russian patent published in 2010 - IPC A61F9/00 A61F9/07 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, specifically to ophthalmology, and may be used for forecasting of inefficient laser descemetogoniopuncture (DTP) long date (more than 3 months) periods after non-penetrating antiglaucomatous operations (AGO). Ultrasound biomicroscopy (UBM) of area of operation and acoustic density (AD), thickness and width of the trabecular-descemet membrane (TDM) are determined, height of intrascleral cavity (ISC) is measured, number of acoustic inclusions in the ISC is estimated, scleral flap (SF) AD is defined, condition of hypoechoic tunnel that connects ISC with the filter bag (FB) is assessed, height and acoustic density of inclusions in the FB are determined, or in the absence of FB acoustic density of the conjunctiva in the area of operation is determined. If the thickness of the TDM is over 0.15 mm, the width of the TDM is less than 0.4 mm, the acoustic density of the TDM over 75%, inefficiency of laser DTP is predicted. If the disappearance of an ISC is detected or an ISC with a height of 0.15 mm or less, completion of ISC with acoustic inclusions, absence of hypoechoic tunnel, the absence of FB, inefficiency of laser DTP is predicted. If there is no possibility to differentiate the boundaries of SF, SF acoustic density exceeds 80%, FB is absent, and the AD of the conjunctiva in the area of operations exceeds 80%, or if the height of FB is less than 0.3 mm, and AD inclusions in the FB is over 80%, inefficiency of laser DTP is predicted.

EFFECT: method allows to increase accuracy of inefficient laser descemetogoniopuncture (DTP) prediction long date (more than 3 months) periods after non-penetrating antiglaucomatous operations (AGO) of ultrasound biomicroscopy (UBM), which provides for laser treatment for cause, improves its efficiency, improves quality of treatment of patients suffering from primary wide-angle glaucoma.

3 ex